Prostate Cancer News on BioPortfolio

MDxHealth Notice of Financial Year 2017 Results

COMPANY ANNOUNCEMENTÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂ ÂÂÂÂ ÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂÂREGULATED INFORMATIONINSIDE INFORMATION MDxHealth Notice of Financial Year 2017 Results Conference call for analysts and investors to be held on 22 February 2018 a...

New mutation linked to ovarian cancer can be passed down through dad

PLOS A newly identified mutation passed down through the Xchromosome is linked to earlier onset of ovarian cancer in women and prostate cancer in father and sons. Kunle Odunsi Kevin H. Eng and colleagues at Roswell Park Comprehensive Cancer Center in Buffa...

FDA Approves Drug to Help Curb a ToughtoTreat Prostate Cancer

WEDNESDAY Feb. 14 2018 A new drug that can stall the progression of a particularly hardtotreat form of prostate cancer has been approved for use by U.S. health officials.In a recent study the drug called Erleada apalutamide has shown...

Pages